FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing…
FDA approves Alzheimer’s drug donanemab after months of delay
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits of modestly slowing the progression of the devastating disease outweigh its risks,…
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN — On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the…
Alzheimer’s drug donanemab gets FDA advisory committee’s green light : Shots
An advisory committee to the Food and Drug Administration has recommended that the federal agency approve Alzheimer’s drug donanemab. Andrew Harnik/AP hide caption toggle caption Andrew Harnik/AP Advisors to the…
FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the…